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Abstract 
In this article we examine illness narratives to illuminate the discursive work that patients 
undertake to construct themselves as ‘good’ and adherent. Biographical narrative 
interviews were undertaken with seventeen patients receiving anticoagulation for stroke 
prevention in atrial fibrillation, from five English hospitals (May 2016 to June 2017). Through 
pluralistic narrative analysis, we highlight the discursive tensions narrators face when 
sharing accounts of their medicine taking. They undertake challenging linguistic and 
performative work to reconcile apparently paradoxical positions. We show how the 
adherent patient is co-constructed through dialogue at the intersection of discourses 
including: authority of doctors; personal responsibility for health; scarcity of resources, and 
deservingness. We conclude that the notion of medication adherence places a hidden moral 
and discursive burden of treatment on patients which they must negotiate when invited 
into conversations about their medications. This discursive work reveals, constitutes and 
upholds medicine-taking as a profoundly moral practice.  
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Introduction 
Pharmaceuticals play an increasing role in the daily life of patients, driven by the 
combination of prescribing for chronic disease management and prescribing to reduce risk 
of disease (and associated healthcare costs), and partly by a burgeoning market in 
medications for long-term conditions (Bell & Figert, 2012; Hardon & Sanabria, 2017). There 
is pressure on clinicians to ‘optimize’ medicines and various cognitive models (Chapman et 
al., 2015; Clifford et al., 2008; Cooper et al., 1982; Munro et al., 2007) have emerged which 
guide prescribing clinicians to assess patients’ attitudes and beliefs towards medication and 
identify barriers to medication use (Murdoch et al., 2014; NICE, 2015). In recent years 
professional discourse has shifted away from paternalistic notions of compliance (Parsons, 
1951) towards ‘medication adherence’ (WHO, 2003), which foregrounds the agreement 
between patient and provider (WHO, 2003). Patients are framed as active partners in their 
care, and the emphasis shifts towards facilitating patient choice (including treatment 
refusal), and reducing blame (NICE, 2009). In practice, however, medication adherence is 
often indistinct from compliance (Trnka, 2014), and critics have long argued for alternative 
conceptions of medicine taking that more accurately account for patient agency, social 
context, meaning making, and experience (Britten, 1996; Chamberlain et al., 2011; Conrad, 
1985; Dew et al., 2014; Donovan & Blake, 1992; Drabble et al., 2019; Huyard et al., 2017; 
Huyard et al., 2019; Lumme-Sandt et al., 2000; McCoy, 2009; Murdoch et al., 2014; Polak, 
2017; Polak & Green, 2020; Pound et al., 2005; Shoemaker & Ramalho de Oliveira, 2008; 
Webster et al., 2009; Werremeyer et al., 2017). For example, ‘medicines resistance’ 
captures the creative, hidden work that patients undertake to minimize, modify and resist 
medication intake (Chamberlain et al., 2011; Murdoch et al., 2013; Pound et al., 2005). 
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Britten (1996) categorized medication accounts as orthodox – justified by medical rationale 
– or unorthodox – self-legitimated, with medicines seen as unnatural, ineffective or 
potentially harmful. More recent work focuses on the routinization of medicine taking, and 
the invisible work of negotiating adherence in competing social spaces (Huyard et al., 2017; 
Huyard et al., 2019; McCoy, 2009; Senteio & Veinot, 2014). May’s (2014) Burden of 
Treatment theory identifies adherence work as requiring significant effort from patients and 
their social networks. It requires the necessary social skills to secure cooperation, show 
structural resilience in the face of adversity, and draw on social capital through access to 
information and material resources. However, previous research has not yet delineated the 
particular ways in which medication adherence as a wider discourse shapes patients’ 
accounts about medicine taking. In this article, we conceptualize talk about medicines as 
part of the work, or burden (May et al., 2014) that patients with long term conditions must 
manage in their everyday interactions. 
Medication adherence is ubiquitous in contemporary healthcare as a guiding principle for 
treatment delivery (NICE, 2009) and as a benchmark for success and comparison between 
medical providers (Seabury et al., 2019). In recent years, consultancy firms have developed 
algorithms for medical datasets that predict future non-adherent behavior and prompt 
clinicians to adapt their prescribing (FICO, 2019). Interest is also turning to the potential 
impact of financial incentives for adherence to drugs (DeFulio & Silverman, 2012; 
Noordraven et al., 2017; Priebe et al., 2013; Volpp et al., 2008). Western media promote the 
message that ‘misuse’ of medicine has a negative impact on the health system and on 
patients (Ledwith, 2013). The New York Times describes non-adherence as an ‘out of control 
epidemic’ that is ‘100% preventable by the very individuals it afflicts’ (Brody, 2017). As 
health systems foreground the importance of individuals taking responsibility for their own 
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health, medication adherence becomes a governing technique signifying the worth and 
identity of the patient (Dew et al., 2015). Non-adherence is simultaneously depicted as a 
patient-related problem to be solved by the health sector, and as a personal failing. This 
invites moral assessments from others regarding how patients use their medicines.  
Morality is concerned with guiding what is deemed right or wrong in particular contexts. A 
moral ‘assemblage’ can be conceptualized as comprised of: circulating public discourses on 
morality, institutional discourses on morality and the personal, embodied dispositions that 
allow for good or acceptable ways of living in the world (Zigon, 2010). Moral dimensions of 
medicine taking are shaped by social, political and historical contexts. The discourse of 
medication adherence speaks to power differentials between medical practitioner and 
patient (Murdoch et al., 2014), and intersects with discourses of personal responsibility and 
blaming of individuals for ill-health (Hill, 2010; Lebesco, 2010), particularly in reference to 
‘intentional’ non-adherence. Alongside notions of self-management and patient activation, 
medicine adherence allows for quantifiable categorizations of ‘appropriate’ patient 
behavior. Preventive medications, predominantly used by older people, can be used to exert 
control over the aging body, in line with neoliberal rationales of positive aging and good 
citizenship (Laliberte Rudman, 2015; Lawless et al., 2017). In the UK, awareness of resource 
scarcity within the publicly funded National Health Service (NHS) leads to judgments about 
the deservingness of other service users (Goode et al., 2004; Griffiths & Hughes, 1994). In 
this context, non-adherence becomes understood as wasting resources and encouraging 
avoidable disease, with associated higher societal and individual costs. Indeed, it has been 
argued that once a patient accepts treatment, they have an obligation to adhere (Glannon & 
Ross, 2002; Resnik, 2005), else they can be considered ‘lazy’, ‘crazy’, ‘difficult’ and ‘defiant’ 
by doctors (Resnik, 2005). Accounting for medication adherence becomes a disciplining 
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technique of the self, aligned with shifts towards healthism and responsibilization in 
neoliberal societies (Crawford, 1980; Kang & Stenfors-Hayes, 2015; Lupton, 1993; Rose, 
1999). 
Going beyond biomedical conceptions of ‘social desirability bias’ in adherence studies, social 
scientists have highlighted the complex moral conditions and repertoires that govern 
medication related talk and usage (Dew et al., 2015; Lumme-Sandt et al., 2000; McMullen & 
Herman, 2009; Murdoch et al., 2013; Polak, 2017). Lumme-Sandt (Lumme-Sandt et al., 
2000) found older patients presented themselves as morally responsible by explaining and 
minimizing their medication use and comparing it to others who took more medicines. 
Similarly, medication talk by non-adherent patients is structured in ways to avoid moral 
judgement (McMullen & Herman, 2009; Murdoch et al., 2013). Medication adherence 
remains a powerful, morally laden discourse that is (re)produced in talk about medicine 
taking. In this article we delineate how medication adherence manifests and is (re)produced 
in patient narratives about medicine taking, as they work to construct and manage adherent 
selves in spite of conflicting positions and tensions. We draw on biographical narratives 
concerning the use of long-term anticoagulants amongst patients with atrial fibrillation (AF).  
AF is a cardiac arrhythmia which increases the risk of ischemic stroke. It affects 1.5-2% of 
the population, with prevalence increasing with age (Camm et al., 2012; Zoni-Berisso et al., 
2014). Anticoagulant medication  for AF prevents around 16,100 strokes a year in the UK 
(Kerr, 2014), but patients taking anticoagulants are more likely to develop bleeding 
complications. For many years warfarin, which requires regular blood tests for INR 
(International Normalization Ratio) monitoring, has been the UK anticoagulant of choice. 
Since 2012 direct oral anticoagulants (DOACs) - apixaban, rivaroxaban, dabigatran and 
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edoxaban - have been available. DOACs require yearly renal function tests (not INR 
monitoring), and have fewer drug and food interactions. In this study we focus on the 
narratives of patients with AF within this shifting context of anticoagulant prescribing. 
Narrative inquiry is concerned with life experiences narrated by those who live them (Chase, 
2013). Narratives can be imagined as emerging from a process of temporal ordering and 
‘sense-making’ at a given moment in time (Sandelowski, 1991). They are everywhere, in 
many guises: spoken narratives range from lengthy biographic life stories (Wengraf, 2001) 
to ‘small’ stories embedded in everyday talk (Bamberg & Georgakopoulou, 2008). To narrate 
one’s life is to account for one’s self, and emerge as a person through the telling (Riessman, 
2003). This is a creative process, shaped in part by dominant narratives that are available in 
the social world. Narratives are not objective accounts, but occasions for creating, revealing, 
re-producing and re-shaping situated subjectivities of the self through interaction. The role 
of the audience, or listener, in the co-construction of narratives is central. Goffman (1959) 
developed a dramaturgical metaphor of narrators ‘performing’ desirable, persuasive selves 
for their audience - real or imagined - shaping the content and form of talk with the listener 
always in mind (Salmon & Riessman, 2013).  
The (co-)construction of a narrative is a moral performance. Bury (2001) defines moral 
narratives as those that introduce an evaluative dimension into the links between the 
personal and the social –shame, blame or religiosity for example. Narrating illness 
experience to an audience can lead the teller to examine their life in moral terms (Hydén, 
1997). Several narratives studies have explored this moral work (Catedral, 2017; Drabble et 
al., 2019; Holdsworth & Robinson, 2008; Knutsen et al., 2011; Murdoch et al., 2013; 
Riessman, 2003; Ryan et al., 2010; Silva, 2013; Williams, 2002). Silva (2013) showed how 
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working class adults narratively framed emotional self-management and overcoming life’s 
obstacles as a matter of individual choice, resulting in harsh moral critiques against others 
who did not achieve self-transformation. Riessman (2003) analyzed how a positive 
masculine identity was narratively achieved in spite of health, employment and marriage 
‘failures’. Ryan (2010) outlined the moral work undertaken by breastfeeding mothers to 
maintain or repair their subjective position in relation to motherhood. In this article we 
extend this body of work with a focus on how people shape their narratives about 
medicines taking through implicit reference to a moral imperative of becoming and being a 
‘good’ and adherent patient. Through revealing this hidden effort we create new avenues 
for conceptualizing and understanding the ‘work’ of taking and talking about medicines in 
research and clinical spaces. 
 
The research 
We conducted a narrative interview study with seventeen patients with AF, recruited from 
outpatient anticoagulant clinics across five hospitals in England. The clinics were selected to 
reflect diversity in terms of demography, geography and type of anticoagulant prescribed. 
Patients over 18 years old who had been diagnosed with atrial fibrillation and who were 
prescribed an oral anticoagulant (OAC) – either warfarin or DOAC – for the prevention of 
stroke were opportunistically given an invitation pack with information about the study 
when they attended their appointment. Interested patients could then be contacted by 
telephone or in writing to discuss the study and ask questions. Patients were informed both 
verbally and via the patient information sheet that participation was voluntary and would 
not affect their care in any way. Patients then responded by posting a signed consent form. 
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We contacted patients to verbally confirm eligibility and consent, and then to arrange an 
interview. We sampled purposively, aiming for maximum diversity of anticoagulant related 
‘experiences’, including exposure (type of anticoagulant, whether they had switched 
medications), gender, age, ethnicity and experience of previous cardiovascular events. 
Recruitment stopped when we had a sufficient range of ‘anticoagulant experiences’ and 
iterative analysis suggested we had reached ‘information power’ (Malterud et al., 2016). 
Patients with cognitive disabilities, those who were housebound or undergoing palliative 
care were not included as recruitment took place in outpatient clinics. All interviews were 
conducted in English.  
We conducted interviews between May 2016 and June 2017 using the Biographic-Narrative-
Interpretive Method (BNIM) (Wengraf, 2001). Ten patients were interviewed at their home, 
and seven in a university office. We piloted the interview schedule with a patient from the 
project advisory panel who had AF and experience of taking both warfarin and DOACs. The 
advisory panel also discussed ethical issues, reviewed patient-facing materials, and provided 
feedback on project design and delivery. Interviews were structured in three parts, 
beginning with a single question used to induce narrative (SQUIN) (Wengraf, 2001) (sub-
session 1, SS1). The SQUIN invited participants to tell their AF story, beginning where they 
wanted and including events and experiences that were important to them. We did not 
interrupt and took brief notes. After a short break, selected cue phrases (actual words 
spoken by the participant) were used to elicit further, more detailed narratives (sub-session 
2, SS2). Cue phrases were used as prompts in the order in which the participant had 
introduced them in SS1. Finally, we used a short semi-structured interview schedule 
(supplementary file), based on the research questions, to enquire about topics not yet 
covered in SS1 or SS2 (sub-session 3, SS3). Formal audio recordings of the entire interview 
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lasted between 32 and 138 minutes, consent for which was provided in writing (consent 
form) and verbally. We spent additional time with participants during the comfort breaks 
and after the formal interview which provided opportunity for informal talk and 
observations which were gathered in a field note journal in addition to a reflexive research 
journal. These notes provided additional contextual information during analysis. Interviews 
were transcribed verbatim and anonymized. Participants received £25 vouchers for their 
time. All participant names given in this manuscript are pseudonyms. 
Data Analysis  
We adopted a pluralistic narrative analytical approach that combined structural (Labov & 
Waletzky, 1997), thematic (Braun & Clarke, 2006), and metaphorical (Lakoff & Johnson, 
2003) lenses. We began by checking the transcripts for accuracy - we carefully listened to 
the audio and checked each transcript twice, whilst cross checking and adding important 
contextual information and non-verbal cues from field notes. Familiarization was reached 
through repeated reading of the transcripts. We then employed structural, thematic and 
metaphorical techniques of analysis as different ‘ways of seeing’ the data. Initially we 
undertook these approaches sequentially; as our analysis progressed and we gained 
increasing familiarity with the data we were able to integrate these approaches, moving 
back and forth between different analytic lenses guided by our iterative analysis and 
emerging findings. 
We classified segments of narrative from SS1 according to Labov’s (1997) six categories of 
clauses (supplementary file 2). We then plotted the main events in a timeline. We noted 
how narrators shifted positions through attention to evaluative clauses. We annotated the 
transcripts with codes by hand, and continued coding, using NVivo software for data 
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management (QSR et al., 2012) in six stages (Braun & Clarke, 2006) (supplementary file 2). 
We identified emerging metaphors line by line and grouped them conceptually according to 
vehicle (subject) (supplementary file 2) for comparison within and across transcripts. 
Metaphors related to body parts (e.g. heart, brain, blood, circulation system); clinical 
processes (e.g. diagnosis and healthcare interactions); drugs; and other health-related 
experiences. Alongside the cross case processes outlined above, we maintained an analytic 
commitment to the ‘whole story’ by collating case findings, reflexive and analytic notes 
within individual summary documents. To further refine the analysis and increase rigor, the 
research team discussed findings from each analytical stage, generating new and alternative 
interpretations and acting as ‘critical friends’. We adapted Wengraf’s (2001) model of ‘panel 
work’ through organizing and conducting three analysis panels, each lasting 2-3 hours and 
focusing on a single transcript. Using ‘reflective teams’ (Jones, 2003) or panels can 
strengthen research findings (Corbally, 2014) and help push the research process along by 
bringing multiple interpretations to the fore. These interpretations were discussed, pulled 
apart and put back together through interactions with others, enriching our ‘sociological 
imagination’, and increasing interpretive depth (Corbally, 2014; Meares, 2010) and 
trustworthiness through peer examination (Phoenix et al., 2016). Each panel consisted of 4-
6 academic researchers (all experienced qualitative researchers, doctoral level or above, 
specializing in disciplinary areas including: anthropology, sociology, medicine, public health, 
linguistics) to interpret three diverse transcripts from the interviews.  
Ethical approval was granted by the North West - Liverpool Central Research Ethics 
Committee, REC Number: 15/NW/0884. Sponsorship approval was provided by the Joint 
Research Management Office on behalf of Queen Mary University of London. Local research 
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and development approvals were sought and granted by the Hospital Trust research team 
for each of the participant identification centers in the study. 
 
Findings 
We interviewed nine women and eight men. Additionally, one participant’s daughter took 
part directly, and another participant’s husband was present but did not contribute verbally. 
Eight patients had taken warfarin only, seven had switched from warfarin to a DOAC, and 
two had taken a DOAC only. Participants ranged from those in their mid-forties to those in 
their eighties (two were 45 – 59; five were 60 – 69; eight were 70 – 79; two were 80 – 85). 
Participants self-identified their ethnicity: twelve White British, one Black African, one Black 
Caribbean, one Chinese, one Indian, and one White Irish. Thirteen had been diagnosed with 
AF over a year previously. Seven had experienced cardiovascular events: (stroke; myocardial 
infarction; major bleed). Nine participants were prescribed at least three medications in 
addition to oral anticoagulants, thus experiencing polypharmacy. Biographical narratives 
involve emotional and mental work and have potential for silencing particular voices – some 
may have trouble in creating a coherent event-focused account (Wengraf, 2001) or may lack 
the discursive resources with which to make sense of their experience and render it tellable 
to others. Without these resources one is at risk of suffering what Fricker (2007) refers to as 
hermeneutical injustice. One participant, who stated she was ‘beginning to lose the plot a 
bit’ struggled with the SQUIN, but participated more comfortably in SS3. 
 
In this section we will outline: how participants constructed adherent selves - morally and 
discursively - through references to gratefulness, expert doctors and ‘good’ medicine 
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practices and through comparison of themselves with non-adherent others. We show how 
they managed the conflicting moral positions of being adherent to medicines and also ‘not 
somebody who takes medicines’ and how they maintained an adherent self whilst also 
reporting non-adherent practices. We also show how they dealt with tensions between 
being adherent to medicines and also taking pleasure in consuming alcohol and foods which 
they knew ‘interfered’ with their prescribed regimens.  
 
The adherent self – ‘I do remember to take my medication good’ 
Narratives about medicine-taking aligned with wider discourses of being a good patient 
through references to being adherent. Adherence was constructed as a virtuous act, whilst 
being non-adherent was undesirable. Participants invested much discursive effort to 
construct adherent selves. One strategy was through references to unquestioning 
acceptance of medical advice through trusting ‘expert’ doctors and expressing gratefulness 
for good fortune in having being ‘given’ medicine. This has been identified elsewhere as a 
‘patient repertoire’, characterized by expressions of contentment with medications (Moen 
et al., 2009) and references to the authority of doctors (Lumme-Sandt et al., 2000), aligning 
with traditional notions of ideal patient ‘sick-role’ behavior (Parsons, 1951) and altruistic 
doctors (Glannon & Ross, 2002). Here a participant, who worked in healthcare and had 
experienced a life-threatening episode prior to her diagnosis, positioned herself as 
accepting of the consultant’s direction and fortunate to have been prescribed a ‘very high 
dose’ of warfarin: 
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‘I was happy to take a tablet. Yeah, when they said, OK, we’ll put you, the consultant came 
to me and said put you on warfarin straight, put you on warfarin. And I said, OK, thank you. 
And I started on a very high dose of warfarin. I was pleased to have that.’ Female participant 
Her job within a hospital may have exposed her to discourses of medication adherence and 
sensitized her to successful ways of positioning herself as adherent. In another respondent’s 
narrative, being adherent to warfarin was also tied to being grateful for medicines, but in 
this case she constructed her good fortune by contrast to others who would not have had 
access to them in the past. The respondent hinted that she tried not to ‘feel sorry for 
herself’, pointing to a reluctance to take her medicine but immediately followed this up by 
clarifying that she was ‘very fortunate that we live in, at this time, because there’s always 
medication and it couldn’t be a better time’.  
In talk about ‘good’ medicine taking, most participants described how it had become a 
‘habit’ and part of their daily routine. One participant described it as follows: ‘I take three in 
the morning and two at night and I never forget. Well I say never but I never forget.’ His use 
of ‘never’ here as an extreme case formulation convinces the listener of his correct behavior 
(Pomerantz, 1986). Similarly another respondent repeated that he forgets to take his 
medication ‘very rarely, very rarely’. In order to avoid forgetting or missing a dose, 
participants referred to using visual and automated reminders, such as using a ‘special 
basket’. One participant was prompted by her television programs, and another kept his 
medicines with the breakfast items. They also described strategies to ensure they could take 
their medicine whilst avoiding conflicts with social expectations. For example, one person 
stated ‘I’m always prepared, I always take medication with me’. Like others, his repeated 
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use of the maximum proportion ‘always’ here substantiates his claim that this is the 
acceptable ‘right’ thing to do (Pomerantz, 1986), solidifying his moral position.  
  
Adherent self vs. ‘People who are given medication and will not do it’ 
Another discursive strategy for articulating the adherent self was by contrasting the ‘good’ 
self with non-adherent others, who were constructed as being ungrateful, wasteful or acting 
childishly or inappropriately. One participant, whose mother had also taken warfarin, 
recalled that her mother was always ‘playing’ with her tablets so they were ‘everywhere’ on 
the floor and tucked down the side of the armchair and she would ‘sit with a nail file and file 
them down!’ leading her to describe her mother as ‘hard work’. Her mother’s actions 
provided contrast to her own more responsible orientation towards her medicines. Another 
narrator stated that she was ‘good’ with medicines through references to having faith in 
doctors and nurses, and not understanding those who are prescribed medication and do not 
take it: 
‘I’m very good with medication as is my husband. I just wonder what these people, what 
world they live in when they do these things, but I suppose they must do it. I’ve still got faith 
in a lot, in doctors and nurses. […] As I say, I can’t understand people who are given 
medication and will not do it. I know you often, you see it don’t you sometimes, people are 
found or they happened and they find all this medication that they’ve, has never taken, all 
stacked up in the cupboard.’ Female participant 
In this passage, she likens the prescription of medication to a gift with the term ‘given’, and 
she engages in a clear example of ‘othering’ emphasized rhetorically through use of a three-
part list (Jefferson, 1990): the actions of ‘these people’; from ‘what world’; who do ‘these 
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things’ – and who by implication are not very good with medication. Her metaphoric hint to 
their living in a different ‘world’ accentuates the gulf between her own virtuous practices 
(and those of her husband) and ‘these people’s’ morally dubious practices. She then goes on 
to make plain that being ‘good with medication’ means taking it and not having it ‘stacked in 
the cupboard’. During the rest of her narrative, this interviewee referred repeatedly to being 
‘of the old school’ and ‘doing what she’s told’, to show her acceptance of medical advice 
without question. Similarly, a different respondent recounted how some friends take un-
prescribed diabetes medication from America, to which she was very opposed, and repeated 
‘I don’t believe in taking these things. I don’t believe in that.’ Her story gave her space to 
construct her adherent self by highlighting the stark contrast between herself and her 
friends. Narratives about the self can be constructed in terms of sameness and difference to 
help explain who the narrator is, and who they are not (Byrne, 2003). For these patients, this 
difference could be characterized as those who are ‘good’ with medicines, and those who 
are not.  
Comparisons to others in terms of gratefulness and adherence often invoked 
complementary discourses around wastefulness of medical resources. By indicating the 
medication ‘all stacked up in the cupboard’, one could assert that ‘these people’ are 
inappropriately storing and wasting medicines, and hint to their eventual discovery as a 
matter of shame. Gratefulness for medicines links to wider discourses of scarcity in the NHS, 
which provokes moral condemnation when people are perceived as resource wasters and 
time wasters (Cromme et al., 2016; Goode et al., 2004) . For example, one person recalled 
watching a documentary about the ambulance service (an ‘eye opener’), explaining ‘when I 
watched it, one woman and one man: “I'm hungry. That's why I need an ambulance to take 
me to the hospital to get fed.” I thought, yeah all right mate.’ Talk about medicines 
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intersected with moral assessments about appropriate use of medical services, drawing on 
and reproducing discourses of deservingness for ‘underfunded’ health care. Indeed, the 
desire to avoid being perceived as an irresponsible consumer of healthcare was so strong for 
one patient that she avoided calling an ambulance while she was experiencing a myocardial 
infarction because she was ‘worried about wasting someone’s time’. 
 
Adherent self vs. ‘I’m not somebody who takes tablets’ 
Dependence on medications is commonly viewed negatively and patients are often reluctant 
to take medicines, or minimize their use (Benson & Britten, 2002; Britten, 1994; Lumme-
Sandt et al., 2000; Polak, 2017; Pound et al., 2005). It is important to avoid being labelled as 
an ‘abuser’ of prescription drugs by peers or professionals (Butler & Sheridan, 2010). The 
virtuous position of being adherent to long term anticoagulants conflicted with a general 
reluctance towards taking medicines or being seen as someone who takes medicines. As one 
female patient explained, ‘I don’t like taking medication. But I know now I have to.’ This 
presented a tension which narrators managed in their talk, often offering apparently 
contradictory accounts, or adopting multiple positions simultaneously. One narrator, for 
instance, described himself as a ‘habitual creature […] so I take God knows what’ including 
fish oils and vitamin tablets. Following this, however, he said that he was ‘not somebody who 
takes tablets’. He explained this further:  
‘I’m grateful that I’m taking it [edoxaban] because I feel safer. I think that’s the thing, but 
whether it actually does anything for, you know, I had a bad knee and I go to the doctor and 
they say, “do you want painkillers?”, I’m like “I don’t want painkillers, I’ll have smarties I’ll 
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just cope with it”. So I’m not somebody who takes tablets, but I feel protected if you know 
what I mean, that’s what I feel.’ Male participant 
One way participants managed these conflicting positions was by reference to different 
properties or categories of medicines. Stronger adherence rules applied to anticoagulant 
medications than painkillers for example. This was because anticoagulants were constructed 
as important or ‘special’ medicines, needed to keep one alive. When a male patient told his 
doctor he wanted to stop taking warfarin, the doctor said she would ‘get the ambulance 
ready’ which convinced him that discontinuing warfarin would represent a real and 
immediate threat to his health, and so he continued taking it. His account of the interaction 
displays his resistance to taking medication and simultaneously legitimises his continued use 
of warfarin by removing the notion that he has a choice, due to the necessity of warfarin for 
survival.  
The moral judgements and penalties relating to non-adherence for anticoagulants were 
greater than those meted out for other medications. For instance, another respondent, who 
had undergone a successful catheter ablation (a surgical procedure to stop abnormal 
electrical activity in the heart tissue) and had previously asked her doctor when she might 
be able to ‘come off’ warfarin, described how she planned to discontinue her tablets for 
blood pressure and cholesterol prior to a clinic appointment, but would not consider doing 
this for warfarin: 
‘Participant: I have the feeling that if you ask, “can I come off it?” They might be reluctant, 
so if I just do it for four weeks beforehand and they might be able to see. 
Interviewer: So what, if you come off the warfarin or? 
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Participant: Not the warfarin, no, I’ll keep, I must keep the warfarin. […] Oh I don’t mess with 
that [warfarin], yeah, no, no, no. 
Interviewer: What’s the difference between the warfarin for you and Ramipril? 
Participant: Because the others can be sorted out by diet and lifestyle, versus having a stroke 
or a heart attack, well pushing up daisies and all that sort of thing. No, no, no, I hope I, I 
think I understand that very well.’ Female participant 
As shown by this passage, she would never consider ‘messing’ with her warfarin (she 
emphasizes this twice in this extract with the persuasive repetition of ‘no, no, no’) – 
positioning it as fundamentally different to her other medications. Here medication non-
adherence was more or less acceptable depending on the type of medicine, and whether 
the effect it had was thought to be achievable through ‘diet and lifestyle’ changes. She 
balances tensions between two social discourses – that of the virtue of medication 
adherence, and of discourses that promote the maintenance of a healthy, slim body through 
physical effort and self-control rather than resorting to or depending on pills (Broom & 
Whittaker, 2004; Crawshaw, 2007; Gonsalves et al., 2016; Lupton & Chapman, 1995). People 
relying on medicines instead of doing the work to keep themselves healthy could be 
considered lazy and immoral, lacking in self-control (Lebesco, 2010). Avoiding these labels is 
important to be considered a worthy patient (Higashi et al., 2013), however it presented 
tensions for participants. One participant, who had experienced a myocardial infarction 
emphasized his ‘really, really fit’ health status and contrasted this with other people who he 
considered ‘massive, absolutely massive’. Another admitted that she was previously 
overweight but then clarified ‘I wasn’t huge, I wasn’t blubber waddling around, I can’t bear 
to see it’. She then went on ‘you don’t even think you’re fat or you’re overweight until 
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suddenly you realize you are. So that going on and on at someone just wouldn’t work, you 
just alienate people’. In the same moment she resists, and reproduces, the stigmatizing 
discourse about overweight bodies. 
 
Adherent self vs. ‘I'm not so great with timings’ 
Some participants worked narratively to overcome a paradox – that of maintaining a ‘good’, 
adherent self, whilst also reporting missing, skipping or stopping their medicines. The 
medication adherence discourse shaped how they told their stories so that they could avoid 
inviting negative judgement from the researcher. 
When patients described non-adherent practices, they did so in ways that convinced the 
interviewer that they knew they had behaved inappropriately. These stories sometimes 
took the structure of a confession, where non-adherence was justified by excusable reasons 
ranging from ‘stupid mistakes’ to lapses of memory accompanied by feelings of guilt, or 
references to ways the narrator could ‘improve’ themselves next time. One patient, for 
instance, recounted how she realized ‘in a panic’ that she had forgotten her tablet and 
organized a reminder to avoid reoccurrence. Socially acceptable reasons for missed doses 
included occasional forgetting, being ill, being fearful of side effects, and changes to daily 
routines. Bury (2001) highlights the ubiquitous nature of the confessional in moral 
narratives. Take this quote in which a participant followed each admission that she 
sometimes takes her anticoagulant medicine a bit later than she ‘should’ by a self-
chastisement, and said that she ‘gets annoyed with herself’:  
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‘So I get up in the morning, I have a cup of coffee and then I have my, take my tablets. But 
then on the Monday and Thursday when it’s my days off I'm not so great with timings. And I 
do know I should sort that out. Perhaps keep my dossette box upstairs or in the en suite or, I 
do need to get better. Or even with refilling the dossette box. If I'm just remembering to take 
them out of the drawer it’s not, probably, it’s probably a couple of hours later than it should 
be. Which I should know better really.’ Female participant 
In this example her repeated comments about knowing and being better can be seen as a 
defense strategy against negative judgement. She later minimizes the occurrence of non-
adherent medicine practices, referring to them as ‘the odd times’ and links them to changes 
in her everyday routine or the location of her medicines. These shifts in inhabited spaces and 
everyday scheduling are known to shape the strategies that patients must use to adhere 
effectively (Huyard et al., 2019). Throughout her narrative she made many comments 
expressing concerns about what other people might think about her actions – including 
being considered a ‘fraud’ on online forums. Like being a fraud, being non-adherent was an 
undesirable position, which she undertook discursive work to avoid.  
Narrators did not only refer to missed or forgotten doses, but also to dosage alterations. 
Here an interviewee admitted: 
‘I have to be honest, sometimes I balanced it [dosage] myself by thinking, no, that doesn’t sit 
right with me, that you’re going to put me from 1.5 warfarin to suddenly 3.5. That was scary. 
So I’d think, no, I’m going to do 2.5, and I’m going to do that for two days, and then, and 
that’s what I found myself doing.’ Female participant 
Her confession works to absolve her of blame, by owning up to her behavior ‘I have to be 
honest’; through reference to fear of taking too much ‘scary’ medication; and through hints 
Page 22 of 36 
 
at the unintentional nature of her actions - ‘that’s what I found myself doing’. In another 
example, a male participant talked about nearly taking too much medication, and described 
this as a mistake: 
‘Well, if you make a mistake and overdo it I think it can cause internal bleeding, I nearly did 
the other day actually [laughs]. But, I’d already taken the tablets first thing and then I was 
filling, I’ve got one of these dispensers, the seven day boxes, and I was getting out a couple of 
5mg ones to put in and I put them in my mouth. And I thought, no, that’s not right. I’d have 
taken 15mg that day, if I’d not stopped, it’s so stupid.’ Male participant 
Here he avoids potential judgement by avoiding blame for his accidental actions, using 
humor as a defensive strategy (Drabble et al., 2019) and also through rectifying his ‘near 
miss’ at the time. He draws on the common understanding that mistakes happen 
occasionally and can be rectified. As these examples show, virtuous adherent selves were 
maintained with discursive practices that helped avoid negative judgement and allowed the 
informants to save face (Goffman, 1959; Murdoch et al., 2013).  
   
Adherent self vs. ‘I’ve got to enjoy myself’ 
In the context of AF and anticoagulants, being a ‘good’, adherent patient didn’t only involve 
taking medicines. For those who took warfarin, rules governed consumption of certain foods 
and drinks especially alcohol, green leafy vegetables, certain fruits and other medicines and 
supplements. In the following passage, one narrator explained how he regulates his alcohol 
intake to avoid affecting his INR levels or AF symptoms. 
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‘If I have a birthday and somebody buys me a bottle of gin, [slaps the back of his hand] 
naughty, naughty. But what I’ve done, I’ve just had a birthday and what I’ve done is if I have 
a gin and tonic now I make sure that I have two capfuls, I undo the top just to, otherwise 
what I used to do, [gestures free pouring] brrr, so you didn’t know how much I was putting 
in. [Laughter] So I have a couple of capfuls and it’s fine.’ Male participant 
Although his INR measurements had been ‘up and down a bit’, he maintains his virtuous 
status in several ways. By slapping his hand and repeating the term ‘naughty’, he invokes a 
chastised child, absolving himself of blame for indulging in alcohol. Discursive positioning as 
children has been documented amongst patients with diabetes to excuse deviance from 
recommended lifestyle changes (Broom & Whittaker, 2004). In this quote he also describes 
changing his behavior to be more careful about the amount of gin he drinks and further 
assures the interviewer he is ‘not a drunken’ and only has ‘one or two’, to avoid negative 
associations with alcohol overconsumption or dependence and loss of control (Butler & 
Sheridan, 2010). He appeals for understanding and exemption from this stigmatizing 
identity by linking drinking with special occasions, in this case his birthday. Similarly, another 
interviewee described eating green vegetables ‘once in a while’ and one mentioned she only 
had ‘Asti’ at Christmas, unlike ‘silly youngsters’. Digressions from approved diets were 
constructed as treats, to be indulged in small amounts, every now and again. Indulging in 
prohibited treats can be used as a way to sweeten the moment (Warin et al., 2015) for 
those living with chronic health conditions or in adverse circumstances, or as a way of 
carving out time for self-care in busy schedules of work and care roles (Graham, 1987).  
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Following the rules was not easy, and required ongoing self-control and work. As one 
respondent pointed out, in order to avoid things interacting with warfarin, ‘you have to 
study’. Another person recounted this conversation with a nurse: 
‘She [nurse] said, “Do you treat yourself, [patient name]?” And I said, “Once in a lifetime”. So 
she said, “Do you eat cakes?” I said, “No”, I said, “but the only thing”, I said, “I do sometimes 
like a jam doughnut”. She said, “[patient name], treat yourself to a jam doughnut now and 
again”. She said, “Don’t”, she said, “you’re one of the good ones”, she said, “Because you 
can, you’re able to control it yourself”. And I know that there’s people in this world even 
younger than I am who have everything done for them. They put, have somebody round 
saying, stop and take this, time you took this. But I control it.’ Male participant 
In this excerpt he legitimizes his occasional ‘treats’ in multiple ways. Alongside his reference 
to having a doughnut ‘once in a lifetime’, the nurse’s reported speech characterizes him as 
‘one of the good ones’ due to his self-control and mastery. Comparing himself to younger 
people who are less independent situates his bodily control and resistance to temptation as 
exceptionally good compared to other people. By pointing out the constant work and 
vigilance that is required, he justifies an occasional release in the form of a sugary doughnut. 
He therefore manages tensions between being seen as someone who adheres to the rules, 
and also legitimately deserves an occasional reward for these efforts. 
 
Discussion 
In this article we have shown how circulating discourses around medication adherence 
shape and are shaped by moral talk about medicines. We have illustrated the ways in which 
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a ‘good’ adherent self was constructed and maintained in moral narratives in the face of 
tensions that arise from concerns about being a pill-taker, and have shown how language 
offers flexible resources that patients can draw on when reporting skipping, missing or 
stopping medicines, or indulging in drinking and eating prohibited foods. The ethical self 
must be managed in line with other intersecting discourses around the authority of doctors, 
responsibility for one’s health, the scarcity of biomedical resources and deservingness. Talk 
in illness narratives arising in research settings is constrained by and reinforces these 
moralizing discourses, and participants must undertake challenging linguistic and 
performative work to reconcile paradoxical positions.  
The interviewer was complicit in the co-construction of the ‘good’ adherent patient self, 
which is shaped by rules of social desirability. Her previous expertise in public health and 
research on medicine taking amongst other patient groups (Hawking et al., 2017; McNulty 
et al., 2015) meant she was aware of how common non-adherence is, and previous failures 
by the research community to meaningfully improve medication adherence prompted her 
to take a more critical perspective when exploring medicine taking and how this evidence is 
constructed. Medical roles and gender have been shown to influence qualitative research, 
the data one collects and the research context (Nelson, 2019; Richards & Emslie, 2000). In 
our case, female participants mostly chose to be interviewed at home, whereas all but one 
male opted to visit the university. Whilst the interviewer communicated to patients that she 
was not a doctor, and interviews were held in non-clinical settings, she was tied to the clinic, 
in part because NHS ethical approval requires patient materials to have clinical references, 
logos and biomedical terminology. Most participants had, unprompted, prepared a pile of 
medical letters, records and medicines prior to the interview. Some structured their SS1 
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narratives as clinical histories (which they were well rehearsed in), with little evaluative talk 
and modest narrative detail. When non-medical details were discussed in the initial 
narratives, some participants would qualify them with comments such as ‘but you don’t 
want to know about that’. Biomedical discourses therefore undoubtedly shaped - and may 
well have constrained – patients’ accounts of their adherent selves, the data we were able 
to collect, and may even have pushed them to work harder than usual to resolve moral and 
positional tensions in their accounts. In response to these challenges, the interviewer 
worked reflexively and flexibly, adapting by maintaining an open and non-judgmental 
position, building rapport and reassuring patients that there were no right or wrong 
answers, and increased prompting for more detail in SS2 with ‘felt’ or ‘emotional’ cue 
phrases rather than ‘clinical detail’ cues. This often led to more candid sharing in later stages 
of the interview. 
Using a SQUIN (Wengraf, 2001) reduces the interviewer’s control in the interview, giving the 
narrator more freedom and space to construct their own accounts compared to alternative 
interview techniques. This can increase the potential credibility of the data. However, there 
is potential to end up collecting ‘thin’ data, or for participants to find it difficult to tell their 
story in an unprompted session, and careful prompting or flexibility in utilization of the 
method is required to avoid facilitate sharing in this case. We ensured trustworthiness of 
our analysis through the systematic use of multiple analytic lenses, which allowed for 
different ‘ways of seeing’ beyond a single analytic approach. Furthermore, the data and 
interpretive findings were critically examined and developed through panel analyses with 
experienced qualitative researchers, and the research team acted as a ‘critical friends’ at 
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every analytic stage. Finally, we kept a reflexive journal, notes of which were included in the 
case summary reports alongside analytic notes and findings.  
Our findings may provide some insight into why reported adherence in research studies is 
highly variable across different medication types and regimen complexity. It may be that the 
additional work of adhering to more challenging medication regimes, or to ‘special’ 
medications such as anticoagulants affords an elevated moral position – adherence in the 
face of particular challenge or burden. This consideration may be particularly pertinent in 
circumstances where adherence becomes visible through monitoring and measurement, 
and a potential subject of moral judgement in questionnaires and interviews. As researchers 
who are interested in medicine taking we may reinforce or reproduce these opportunities 
for ethics to emerge, upholding medicine taking as a moral practice. 
We included patients with a diverse range of experiences and backgrounds from a broad 
geographic area and differing clinical contexts, to increase the potential transferability of 
our findings. However, all participants who responded to our invitation self-selected, and 
would probably be considered adherent by medical professionals, where definitions of 
‘acceptable’ adherers include those who take anticoagulants according to prescription 80% 
of the time, (Mueller et al., 2017), or who self-report that they usually undertake adherent 
behavior. None of the interviewees reported discontinuing their anticoagulants or changing, 
skipping or forgetting doses ‘often’ in their accounts. We were unable to recruit any patients 
who had independently discontinued their anticoagulant medication, in part a limitation of 
our approach to recruitment, which took place in medical settings with clinical staff. We 
reassured patients that taking part would not affect their medical care, however the 
findings are therefore most pertinent to patients who – broadly speaking – consider 
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themselves to be adherent medicine takers. That patients are invested in constructing and 
maintaining an adherent self in medical research settings provides insight into why those 
who discontinue or modify their anticoagulant regimes might not have responded. Not 
responding can be interpreted as a form of resisting judgement, of rejecting a request to 
account for one’s own actions in line with discourses that blame and moralize decisions 
about and practices around medicines. Like others (Murdoch et al., 2014), our findings 
problematize the binary categorization of people as ‘adherent’ and ‘non-adherent’ that is 
common in biomedical research on medicine taking. This binary belies the complexity of 
medicine taking as a practice and encourages comparisons between patients.  
We have shown that in some situations moral discourses may support medicine taking, but 
may also prevent disclosure of non-adherent practices. For clinicians, supporting patient 
medicine taking is challenging in short clinical appointments, particularly in light of our 
findings. Medication reviews are key opportunities to support patients – but questions must 
be non-judgmental and open to invite talk from the patient agenda and overcome the 
pressure for patients to perform linguistically as ‘adherent’. This would contribute to efforts 
towards patient-centered care and true shared decision making (Charles et al., 1997; 
Constand et al., 2014; Mead & Bower, 2000). Clinicians must expect medication practices to 
change over time, particularly for long term medications, and see adherence as an ongoing, 
complex practice that requires regular follow up rather than a one off assessment or binary 
categorization. Medication taking can be supported by addressing concerns and focusing on 
practical solutions (Chapman et al., 2015; NICE, 2009), but this still relies on patients being 
able to openly discuss their medicine taking without judgement. Challenging moralizing 
discourses with comments such as ‘many patients struggle with taking their medicines, and 
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this does not mean they have done anything wrong’ may also be useful. All this may not be 
effective, however, if clinicians continue to linguistically reproduce circulating discourses 
around the authority of doctors and personal responsibility for health, which may also drive 
the ‘good’ patient narrative.  
The normative medication adherence discourse is not neutral; it has consequences which 
can be unhelpful to patients and practitioners. It takes significant discursive work to 
construct and maintain an adherent self, and benefit from the morally acceptable position it 
affords in the eyes of others, including researchers and health care professionals. Drawing 
on May’s (2014) Burden of Treatment Theory, we can interpret this discursive effort – or 
discursive burden – as an additional facet of the work identified as ‘social skill’ that is 
required to secure cooperation and collaboration from those in relational networks, 
including making the most of opportunities to access and utilize healthcare resources. 
Patients within these networks are accountable for their behavior and governed by 
expectations about what is right and good. Notions such as ‘shared decision making’ and 
‘autonomous, empowered patients’ (Charles et al., 1997; Constand et al., 2014; Mead & 
Bower, 2000) may be at risk of buckling under the discursive pressure of medication 
adherence and the moral imperatives it summons for patients in their encounters with 
professionals. By pressuring patients towards being ‘good’, this discursive burden has the 
potential to close down candid conversations that would actually help support long term 
medicine taking in a patient-centered way. We should be aware of this burden for patients 
who decide to take medicines, and are called upon to discuss their medicines regularly in 
clinical spaces (and sometimes in research spaces). Whilst the concept of adherence claims 
to offer patients autonomy in medicine related decisions (WHO, 2003), patients must work 
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hard to avoid moral condemnation when they make decisions which conflict with norms 
governing ‘appropriate’ illness behaviors. Our findings suggest that clinicians may also have 
to work hard to achieve a genuine patient-centered consultation in this context, recognizing 
the discursive burden experienced by patients taking medicines and providing opportunities 
for additional support. In order to overcome the pressure to be ‘good’ and adherent, 
patients may need extra space to express their medicine-related concerns and perceptions 
without judgement, and clinicians need to create this space. 
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